Scientists say you can now use Osimertinib -a cancer drug- just once a week instead of daily and still be safe from tumour regrowths.
Researchers at IIT Bombay develop a shockwave-based needle-free syringe that ensures painless and safe drug delivery with lesser damage to skin and lower risk of infection